HLHRUXO: a prospective trial of a ruxolitinib-containing regimen for children with hemophagocytic lymphohistiocytosis.

Meyer LK, Ryan K, Panetta JC, Crews KR, Albeituni S, Degar BA, Hermiston ML, Talano JM, Torno LL, Zambidis ET, Trone DJ, Sabin ND, Maron G, Flerlage T, Thomas PG, Cheng C, Campbell PK, Nichols KE, Hines MR

Open source

DOI: 10.1182/bloodadvances.2026020265
Published: 2026 Aug 11
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2026020265,
  title = {HLHRUXO: a prospective trial of a ruxolitinib-containing regimen for children with hemophagocytic lymphohistiocytosis.},
  author = {Meyer LK and Ryan K and Panetta JC and Crews KR and Albeituni S and Degar BA and Hermiston ML and Talano JM and Torno LL and Zambidis ET and Trone DJ and Sabin ND and Maron G and Flerlage T and Thomas PG and Cheng C and Campbell PK and Nichols KE and Hines MR},
  year = {2026},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2026020265},
  url = {https://doi.org/10.1182/bloodadvances.2026020265}
}

RIS

TY  - JOUR
TI  - HLHRUXO: a prospective trial of a ruxolitinib-containing regimen for children with hemophagocytic lymphohistiocytosis.
AU  - Meyer LK
AU  - Ryan K
AU  - Panetta JC
AU  - Crews KR
AU  - Albeituni S
AU  - Degar BA
AU  - Hermiston ML
AU  - Talano JM
AU  - Torno LL
AU  - Zambidis ET
AU  - Trone DJ
AU  - Sabin ND
AU  - Maron G
AU  - Flerlage T
AU  - Thomas PG
AU  - Cheng C
AU  - Campbell PK
AU  - Nichols KE
AU  - Hines MR
PY  - 2026
JO  - Blood advances
DO  - 10.1182/bloodadvances.2026020265
UR  - https://doi.org/10.1182/bloodadvances.2026020265
ER  -

APA

LK, M., K, R., JC, P., KR, C., S, A., BA, D., ML, H., JM, T., LL, T., ET, Z., DJ, T., ND, S., G, M., T, F., PG, T., C, C., PK, C., KE, N., & MR, H. (2026). HLHRUXO: a prospective trial of a ruxolitinib-containing regimen for children with hemophagocytic lymphohistiocytosis.. Blood advances. https://doi.org/10.1182/bloodadvances.2026020265

Source records

pubmed · retrieved 2026-09-27T09:30:03.121Z
europe-pmc · retrieved 2026-09-27T09:30:03.120Z